|
|
FACT Announces New Accreditations;
Accredited Facilities Now Total 150
Three blood and marrow transplant facilities earned accreditation and one additional program received accreditation renewal during October and November, according to the Foundation for the Accreditation of Cellular Therapy (FACT).
FACT is a non-profit voluntary foundation for standard-setting, self-assessment, inspection and accreditation in all phases of hematopoietic collection, processing and transplantation. It is jointly sponsored by ASBMT and the International Society for Cellular Therapy (ISCT).
The accreditation actions were:
NEW ACCREDITATIONS
Allogeneic and autologous marrow and peripheral blood progenitor cell transplantation, including collection and laboratory processing:
- McGill University Health Centre Stem Cell Transplant Program, Montreal, Quebec, Canada
Program Director: Ahmed Galal, MD
- Programme de transplantation hématopoïétique, Centre Hospitalier Universitaire Mère-enfant Sainte-Justine, Université de Montréal, Montreal, Quebec, Canada
Program Director: Martin Champagne, MD
- University
of Kentucky Blood and Marrow Transplant Program, Lexington, Kentucky
Program Director: Martin Champagne, MD
ACCREDITATION RENEWALS
Autologous peripheral blood progenitor cell transplantation, including collection and laboratory processing:
- Marshfield Clinic, Saint Joseph's Hospital, Hematopoietic Progenitor Cell Transplant Program, Marshfield, Wisconsin
Program Director: Richard Mercier, MD
Currently there are 150 accredited blood and marrow transplant facilities, and 36 additional facilities are in various stages of application and inspection. Eleven cord blood banks have FACT/NetCord accreditation, and 37 additional banks in 16 countries have applied for accreditation.
For a complete list of accredited facilities and additional information about FACT accreditation, visit the FACT Web site.
|